| Quality of life of stroke survivors in Africa: a systematic review and meta-analysis UM Bello, M Chutiyami, D Salihu, SI Abdu, BA Tafida, AA Jabbo, ... Quality of Life Research 30, 1-19, 2021 | 34 | 2021 |
| Design of potential anti-melanoma agents against SK-MEL-5 cell line using QSAR modeling and molecular docking methods AB Umar, A Uzairu, GA Shallangwa, S Uba SN Applied Sciences 2 (5), 1-18, 2020 | 28 | 2020 |
| QSAR modeling for the prediction of pGI50 activity of compounds on LOX IMVI cell line and ligand-based design of potent compounds using in silico virtual screening BA Umar, A Uzairu, GA Shallangwa, U Sani Network Modeling Analysis in Health Informatics and Bioinformatics 8 (1), 22, 2019 | 25 | 2019 |
| Virtual molecular docking study of some novel carboxamide series as new anti-tubercular agents M Abdullahi, A Uzairu, GA Shallangwa, DE Arthur, BA Umar, MT Ibrahim European Journal of Chemistry 11 (1), 30-36, 2020 | 24 | 2020 |
| QSAR studies on some C14-urea tetrandrine compounds as potent anti-cancer against leukemia cell line (K562) A Mustapha, G Shallangwa, MT Ibrahim, AU Bello, DA Ebuka, A Uzairu, ... Journal of the Turkish Chemical Society Section A: Chemistry 5 (3), 1387-1398, 2018 | 24 | 2018 |
| Docking-based strategy to design novel flavone-based arylamides as potent V600E-BRAF inhibitors with prediction of their drug-likeness and ADMET properties AB Umar, A Uzairu, GA Shallangwa, S Uba Bulletin of the National Research Centre 44, 1-11, 2020 | 22 | 2020 |
| In silico evaluation of some 4-(quinolin-2-yl) pyrimidin-2-amine derivatives as potent V600E-BRAF inhibitors with pharmacokinetics ADMET and drug-likeness predictions AB Umar, A Uzairu, GA Shallangwa, S Uba Future Journal of Pharmaceutical Sciences 6 (1), 61, 2020 | 22 | 2020 |
| QSAR modelling and molecular docking studies for anti-cancer compounds against melanoma cell line SK-MEL-2 AB Umar, A Uzairu, GA Shallangwa, S Uba Heliyon 6 (3), e03640, 2020 | 22 | 2020 |
| In-silico activity prediction, structure-based drug design, molecular docking and pharmacokinetic studies of selected quinazoline derivatives for their antiproliferative … SH Abdullahi, A Uzairu, GA Shallangwa, S Uba, AB Umar Bulletin of the National Research Centre 46 (1), 2, 2022 | 21 | 2022 |
| Molecular design and docking analysis of the inhibitory activities of some α_substituted acetamido-N-benzylacetamide as anticonvulsant agents U Abdulfatai, S Uba, BA Umar, MT Ibrahim SN Applied Sciences 1, 1-8, 2019 | 21 | 2019 |
| Chemo-informatics activity prediction, ligand based drug design, Molecular docking and pharmacokinetics studies of some series of 4, 6-diaryl-2-pyrimidinamine derivatives as … SH Abdullahi, A Uzairu, MT Ibrahim, AB Umar Bulletin of the National Research Centre 45, 1-22, 2021 | 20 | 2021 |
| Viral suppression among HIV-positive patients on antiretroviral therapy in northwestern Nigeria: an eleven-year review of tertiary care centre records, January 2009–December 2019 SB Abdullahi, OR Ibrahim, AB Okeji, RI Yandoma, I Bashir, S Haladu, ... BMC Infectious Diseases 21, 1-8, 2021 | 15 | 2021 |
| QSAR, molecular docking, and design of novel 4-(N, N-diarylmethyl amines) Furan-2 (5H)-one derivatives as insecticides against Aphis craccivora Y Isyaku, A Uzairu, S Uba, MT Ibrahim, AB Umar Bulletin of the National Research Centre 44 (1), 1-11, 2020 | 15 | 2020 |
| Ligand-based drug design and molecular docking simulation studies of some novel anticancer compounds on MALME-3M melanoma cell line AB Umar, A Uzairu, GA Shallangwa, S Uba Egyptian Journal of Medical Human Genetics 22, 1-15, 2021 | 14 | 2021 |
| Computational modeling, ligand-based drug design, drug-likeness and ADMET properties studies of series of chromen-2-ones analogues as anti-cancer agents SH Abdullahi, A Uzairu, GA Shallangwa, S Uba, AB Umar Bulletin of the National Research Centre 46 (1), 177, 2022 | 13 | 2022 |
| Rational drug design of potent V600E-BRAF kinase inhibitors through molecular docking simulation BA Umar, A Uzairu, GA Shallangwa, S Uba The Journal of Engineering and Exact Sciences 5 (5), 0469-0481, 2019 | 13 | 2019 |
| Molecular docking, ADMET and pharmacokinetic properties predictions of some di-aryl pyridinamine derivatives as estrogen receptor (Er+) kinase inhibitors SH Abdullahi, A Uzairu, GA Shallangwa, S Uba, AB Umar Egyptian Journal of Basic and Applied Sciences 9 (1), 180-204, 2022 | 12 | 2022 |
| Virtual screening, pharmacokinetic, and DFT studies of anticancer compounds as potential V600E-BRAF kinase inhibitors AB Umar, A Uzairu Journal of Taibah University Medical Sciences 18 (5), 933-946, 2023 | 11 | 2023 |
| Computational evaluation of potent 2-(1H-imidazol-2-yl) pyridine derivatives as potential V600E-BRAF inhibitors AB Umar, A Uzairu, GA Shallangwa, S Uba Egyptian Journal of Medical Human Genetics 21 (1), 67, 2020 | 10 | 2020 |
| Understanding inhibition of steel corrosion by some potent triazole derivatives of pyrimidine through density functional theory and molecular dynamics simulation studies A BELLO, A Uzairu, GA Shallangwa Journal of the Turkish Chemical Society Section A: Chemistry 6 (3), 451-462, 2019 | 10 | 2019 |
